Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1

Interventions

Radiosurgery 58Radiotherapy 43Magnetic Resonance Spectroscopy 39Cyclophosphamide 34Standard of Care 30Surveys and Questionnaires 22Dexamethasone 19Educational Status 18Therapeutics 17Exercise 17Radiation 16Magnetic Resonance Imaging 16fludarabine phosphate 15Proton Therapy 15Practice Guidelines as Topic 15Methods 15Mammography 15Fluorodeoxyglucose F18 15Cisplatin 15Blood Specimen Collection 15Acupuncture Therapy 15Doxorubicin 14fludarabine 13Positron-Emission Tomography 13Calcium Dobesilate 13Biopsy 13Surgical Procedures, Operative 12Radiotherapy, Intensity-Modulated 12Palliative Care 12Indocyanine Green 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Has results × ferumoxtran-10 × Clear all
NCT00147238 2012-08-07

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

M.D. Anderson Cancer Center

Phase NA Terminated
10 enrolled 3 charts
Genitourinary

Urinary Bladder Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡